Trial Profile
A study assessing real-world experiences of use of aflibercept in patients with stage IV colorectal cancer in the North-West of England
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Oct 2016
Price :
$35
*
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Irinotecan
- Indications Colorectal cancer
- Focus Adverse reactions; Therapeutic Use
- 16 Oct 2016 New trial record